Problems in diagnostics of primary aldosteronism - analysis of the own data

被引:0
作者
Mysliwiec, Janusz [1 ]
Zukowski, Lukasz [1 ]
Grodzka, Anna [1 ]
Pilaszewicz, Agata [1 ]
Dragowski, Szymon [1 ]
Piekut, Beata [1 ]
Nikolajuk, Agnieszka [1 ]
Gorska, Maria [1 ]
机构
[1] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Dis, PL-15276 Bialystok, Poland
关键词
aldosterone; renin; hypertension; primary aldosteronism; RENIN-ACTIVITY RATIO; ADRENALECTOMY; PREVALENCE; HYPERTENSION; ADENOMAS; FORMS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: During the last few years, increasing evidence suggests that primary aldosteronism is the cause of over 10% of arterial hypertension (AH). There are no "gold standard" methods for PA screening. The aim of study was plasma renin activity (PRA), plasma aldosterone concentration (PAC), and ARR assessment as criteria for diagnosis of PA and their usefulness in clinical practice. Material and methods: Eighty-one consecutive patients were admitted for diagnosis of primary aldosteronism: 51 women and 30 men, aged 31-69 years. In each patient, PAC and PRA were evaluated by radioimmunoassay. In 65 patients, urine concentration of catecholamine metabolites was assayed, and in 51 patients, diagnostics for hypercortisolaemia was carried out. In patients with adrenal incidentaloma, 16-row computer tomography was performed. Results: The proportion of patients with PAC over 150 pg/ml was 35% (n = 28). The number of patients with PRA under 0.07 ng/ml/h was 19 (n = 15). The ratio of patients whose values of ARR exceeded over 20, 30, 40, 50, and 180 were 55, 47, 37, 28, and 15%, respectively. Conclusions: The most common indication for primary screening was the presence of incidentally found adrenal mass. The quotient of plasma aldosterone concentration/plasma renin activity at whichever cut-off point is not effective enough for the selection of patients for further diagnostics or its cessation. (Pol J Endocrinol 2010; 61 (1): 2-5)
引用
收藏
页码:2 / 5
页数:4
相关论文
共 14 条
  • [1] Calhoun David A, 2006, J Clin Hypertens (Greenwich), V8, P181, DOI 10.1111/j.1524-6175.2006.04747.x
  • [2] Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
    Douma, Stella
    Petidis, Konstantinos
    Doumas, Michael
    Papaefthimiou, Panagiota
    Triantafyllou, Areti
    Kartali, Niki
    Papadopoulos, Nikolaos
    Vogiatzis, Konstantinos
    Zamboulis, Chrysanthos
    [J]. LANCET, 2008, 371 (9628) : 1921 - 1926
  • [3] Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
    Funder, John W.
    Carey, Robert M.
    Fardella, Carlos
    Gomez-Sanchez, Celso E.
    Mantero, Franco
    Stowasser, Michael
    Young, William F., Jr.
    Montori, Victor M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) : 3266 - 3281
  • [4] Lumachi F, 2005, AM SURGEON, V71, P864
  • [5] Extensive personal experience - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
    Mulatero, P
    Stowasser, M
    Loh, KC
    Fardella, CE
    Gordon, RD
    Mosso, L
    Gomez-Sanchez, CE
    Veglio, F
    Young, WF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) : 1045 - 1050
  • [6] Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism
    Mulatero, P
    Rabbia, F
    Milan, A
    Paglieri, C
    Morello, F
    Chiandussi, L
    Veglio, F
    [J]. HYPERTENSION, 2002, 40 (06) : 897 - 902
  • [7] Aldosterone: A risk factor for vascular disease
    Neves, MF
    Schiffrin, EL
    [J]. CURRENT HYPERTENSION REPORTS, 2003, 5 (01) : 59 - 65
  • [8] Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension
    Nishizaka, MK
    Pratt-Ubunama, M
    Zaman, MA
    Cofield, S
    Calhoun, DA
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (06) : 805 - 812
  • [9] Outcomes of laparoscopic adrenalectomy for hyperladosteronism
    Pang, Tony C.
    Bambach, Chris
    Monaghan, Judith C.
    Sidhu, Stan B.
    Bune, Alex
    Delbridge, Leigh W.
    Sywak, Mark S.
    [J]. ANZ JOURNAL OF SURGERY, 2007, 77 (09) : 768 - 773
  • [10] Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling
    Pu, Q
    Neves, MF
    Virdis, A
    Touyz, RM
    Schiffrin, EL
    [J]. HYPERTENSION, 2003, 42 (01) : 49 - 55